• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe infusion reaction, anti-rituximab antibodies and lymphoma.

作者信息

Kidoguchi K, Kubota Y, Kusaba K, Kizuka-Sano H, Yamaguchi K, Nishioka A, Yokoo M, Ando T, Kojima K, Kimura S

机构信息

Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.

Department of Transfusion Medicine, Saga University Hospital, Saga, Japan.

出版信息

QJM. 2020 Apr 1;113(4):273-274. doi: 10.1093/qjmed/hcz296.

DOI:10.1093/qjmed/hcz296
PMID:31702763
Abstract
摘要

相似文献

1
Severe infusion reaction, anti-rituximab antibodies and lymphoma.严重输注反应、抗利妥昔单抗抗体与淋巴瘤
QJM. 2020 Apr 1;113(4):273-274. doi: 10.1093/qjmed/hcz296.
2
Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中抗CD20输注相关严重难治性休克的致病性研究
Leuk Lymphoma. 2006 Jan;47(1):111-5. doi: 10.1080/10428190500254752.
3
Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG.一名复发性滤泡性非霍奇金淋巴瘤患者在接受抗CD20治疗后出现长时间中性粒细胞减少，并通过静脉注射免疫球蛋白得到纠正。
Ann Oncol. 2001 Oct;12(10):1493-4. doi: 10.1023/a:1012500524758.
4
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.含抗CD20抗体方案治疗复发或难治性慢性淋巴细胞白血病、弥漫性大B细胞淋巴瘤或滤泡性淋巴瘤患者的循证综述
Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):508-518.e14. doi: 10.1016/j.clml.2018.05.009. Epub 2018 May 23.
5
Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy.采用抗CD20抗体利妥昔单抗和低剂量累及野放疗治疗原发性结膜滤泡性淋巴瘤。
Jpn J Ophthalmol. 2007 Mar-Apr;51(2):149-51. doi: 10.1007/s10384-006-0407-0. Epub 2007 Apr 6.
6
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response.一项在滤泡性淋巴瘤患者中使用利妥昔单抗（嵌合抗CD20单克隆抗体）的英国多中心II期研究，并通过聚合酶链反应监测分子反应。
Br J Haematol. 2000 Apr;109(1):81-8. doi: 10.1046/j.1365-2141.2000.01965.x.
7
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.利妥昔单抗抗CD20单克隆抗体疗法治疗非霍奇金淋巴瘤：再次治疗的安全性和疗效
J Clin Oncol. 2000 Sep;18(17):3135-43. doi: 10.1200/JCO.2000.18.17.3135.
8
Rituximab-induced vasculitis: Does the immune complex of rituximab play a key role in developing paradoxical adverse events?利妥昔单抗诱导的血管炎：利妥昔单抗的免疫复合物在引发矛盾性不良事件中起关键作用吗？
J Dermatol. 2019 Sep;46(9):e311-e312. doi: 10.1111/1346-8138.14872. Epub 2019 Apr 10.
9
Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis.
Leuk Lymphoma. 2007 Feb;48(2):437-8. doi: 10.1080/10428190601078134.
10
Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy.高效抗CD20抗体治疗导致的肠道淋巴瘤穿孔
Transplantation. 2002 Feb 27;73(4):669-70. doi: 10.1097/00007890-200202270-00038.

引用本文的文献

1
Rituximab induced cytokine release syndrome in an MS patient: A case report.利妥昔单抗诱发一名多发性硬化症患者发生细胞因子释放综合征：病例报告。
Clin Case Rep. 2021 Jul 9;9(7):e04407. doi: 10.1002/ccr3.4407. eCollection 2021 Jul.